UniProt ID | PKN1_HUMAN | |
---|---|---|
UniProt AC | Q16512 | |
Protein Name | Serine/threonine-protein kinase N1 | |
Gene Name | PKN1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 942 | |
Subcellular Localization |
Cytoplasm . Nucleus . Endosome . Cell membrane Peripheral membrane protein . Cleavage furrow . Midbody . Associates with chromatin in a ligand-dependent manner. Localization to endosomes is mediated via its interaction with RHOB. Association to the |
|
Protein Description | PKC-related serine/threonine-protein kinase involved in various processes such as regulation of the intermediate filaments of the actin cytoskeleton, cell migration, tumor cell invasion and transcription regulation. Part of a signaling cascade that begins with the activation of the adrenergic receptor ADRA1B and leads to the activation of MAPK14. Regulates the cytoskeletal network by phosphorylating proteins such as VIM and neurofilament proteins NEFH, NEFL and NEFM, leading to inhibit their polymerization. Phosphorylates 'Ser-575', 'Ser-637' and 'Ser-669' of MAPT/Tau, lowering its ability to bind to microtubules, resulting in disruption of tubulin assembly. Acts as a key coactivator of androgen receptor (ANDR)-dependent transcription, by being recruited to ANDR target genes and specifically mediating phosphorylation of 'Thr-11' of histone H3 (H3T11ph), a specific tag for epigenetic transcriptional activation that promotes demethylation of histone H3 'Lys-9' (H3K9me) by KDM4C/JMJD2C. Phosphorylates HDAC5, HDAC7 and HDAC9, leading to impair their import in the nucleus. Phosphorylates 'Thr-38' of PPP1R14A, 'Ser-159', 'Ser-163' and 'Ser-170' of MARCKS, and GFAP. Able to phosphorylate RPS6 in vitro.. | |
Protein Sequence | MASDAVQSEPRSWSLLEQLGLAGADLAAPGVQQQLELERERLRREIRKELKLKEGAENLRRATTDLGRSLGPVELLLRGSSRRLDLLHQQLQELHAHVVLPDPAATHDGPQSPGAGGPTCSATNLSRVAGLEKQLAIELKVKQGAENMIQTYSNGSTKDRKLLLTAQQMLQDSKTKIDIIRMQLRRALQAGQLENQAAPDDTQGSPDLGAVELRIEELRHHFRVEHAVAEGAKNVLRLLSAAKAPDRKAVSEAQEKLTESNQKLGLLREALERRLGELPADHPKGRLLREELAAASSAAFSTRLAGPFPATHYSTLCKPAPLTGTLEVRVVGCRDLPETIPWNPTPSMGGPGTPDSRPPFLSRPARGLYSRSGSLSGRSSLKAEAENTSEVSTVLKLDNTVVGQTSWKPCGPNAWDQSFTLELERARELELAVFWRDQRGLCALKFLKLEDFLDNERHEVQLDMEPQGCLVAEVTFRNPVIERIPRLRRQKKIFSKQQGKAFQRARQMNIDVATWVRLLRRLIPNATGTGTFSPGASPGSEARTTGDISVEKLNLGTDSDSSPQKSSRDPPSSPSSLSSPIQESTAPELPSETQETPGPALCSPLRKSPLTLEDFKFLAVLGRGHFGKVLLSEFRPSGELFAIKALKKGDIVARDEVESLMCEKRILAAVTSAGHPFLVNLFGCFQTPEHVCFVMEYSAGGDLMLHIHSDVFSEPRAIFYSACVVLGLQFLHEHKIVYRDLKLDNLLLDTEGYVKIADFGLCKEGMGYGDRTSTFCGTPEFLAPEVLTDTSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSAEAIGIMRRLLRRNPERRLGSSERDAEDVKKQPFFRTLGWEALLARRLPPPFVPTLSGRTDVSNFDEEFTGEAPTLSPPRDARPLTAAEQAAFLDFDFVAGGC | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MASDAVQSE ------CCCHHHCCC | 19.00 | 22814378 | |
3 | Phosphorylation | -----MASDAVQSEP -----CCCHHHCCCC | 25.46 | - | |
8 | Phosphorylation | MASDAVQSEPRSWSL CCCHHHCCCCCHHHH | 42.86 | 25850435 | |
12 | Phosphorylation | AVQSEPRSWSLLEQL HHCCCCCHHHHHHHH | 31.56 | 24719451 | |
14 | Phosphorylation | QSEPRSWSLLEQLGL CCCCCHHHHHHHHCC | 25.07 | 27251275 | |
18 (in isoform 2) | Phosphorylation | - | 40.58 | 24719451 | |
51 | Ubiquitination | REIRKELKLKEGAEN HHHHHHHHHHHHHHH | 59.61 | 24816145 | |
53 | Ubiquitination | IRKELKLKEGAENLR HHHHHHHHHHHHHHH | 53.14 | - | |
57 | Ubiquitination | LKLKEGAENLRRATT HHHHHHHHHHHHHHH | 68.59 | 24816145 | |
59 (in isoform 2) | Ubiquitination | - | 2.70 | - | |
63 | Phosphorylation | AENLRRATTDLGRSL HHHHHHHHHHHHHHH | 21.02 | 23403867 | |
63 | Ubiquitination | AENLRRATTDLGRSL HHHHHHHHHHHHHHH | 21.02 | 24816145 | |
64 | Phosphorylation | ENLRRATTDLGRSLG HHHHHHHHHHHHHHC | 28.39 | 10467162 | |
69 | Phosphorylation | ATTDLGRSLGPVELL HHHHHHHHHCHHHHH | 35.56 | 22617229 | |
75 (in isoform 2) | Phosphorylation | - | 5.78 | 24719451 | |
80 | Phosphorylation | VELLLRGSSRRLDLL HHHHHCCCHHHHHHH | 17.78 | 23186163 | |
81 | Phosphorylation | ELLLRGSSRRLDLLH HHHHCCCHHHHHHHH | 25.01 | 23186163 | |
86 (in isoform 2) | Phosphorylation | - | 5.64 | 27251275 | |
106 | Phosphorylation | VLPDPAATHDGPQSP ECCCCCCCCCCCCCC | 23.70 | 28464451 | |
112 | Phosphorylation | ATHDGPQSPGAGGPT CCCCCCCCCCCCCCC | 28.56 | 28464451 | |
118 (in isoform 2) | Phosphorylation | - | 29.34 | 27251275 | |
119 | Phosphorylation | SPGAGGPTCSATNLS CCCCCCCCCCCCCHH | 23.51 | 22210691 | |
121 | Phosphorylation | GAGGPTCSATNLSRV CCCCCCCCCCCHHHH | 40.38 | 28122231 | |
123 | Phosphorylation | GGPTCSATNLSRVAG CCCCCCCCCHHHHCC | 22.02 | 28122231 | |
126 | Phosphorylation | TCSATNLSRVAGLEK CCCCCCHHHHCCCCH | 27.12 | 28122231 | |
167 (in isoform 2) | Ubiquitination | - | 24.79 | - | |
173 | Phosphorylation | AQQMLQDSKTKIDII HHHHHHCCCCHHHHH | 29.30 | 22210691 | |
175 | Phosphorylation | QMLQDSKTKIDIIRM HHHHCCCCHHHHHHH | 36.86 | 22210691 | |
202 | Phosphorylation | NQAAPDDTQGSPDLG CCCCCCCCCCCCCCC | 42.06 | 28450419 | |
205 | Phosphorylation | APDDTQGSPDLGAVE CCCCCCCCCCCCCEE | 12.86 | 21712546 | |
233 | Ubiquitination | HAVAEGAKNVLRLLS HHHHHHHHHHHHHHH | 59.45 | 24816145 | |
239 | Ubiquitination | AKNVLRLLSAAKAPD HHHHHHHHHHCCCCC | 2.37 | 24816145 | |
240 | Phosphorylation | KNVLRLLSAAKAPDR HHHHHHHHHCCCCCH | 30.67 | 19664994 | |
243 | Acetylation | LRLLSAAKAPDRKAV HHHHHHCCCCCHHHH | 61.23 | 25953088 | |
243 | Ubiquitination | LRLLSAAKAPDRKAV HHHHHHCCCCCHHHH | 61.23 | 24816145 | |
245 | Ubiquitination | LLSAAKAPDRKAVSE HHHHCCCCCHHHHHH | 41.03 | 24816145 | |
246 (in isoform 2) | Phosphorylation | - | 70.36 | 24719451 | |
249 | Ubiquitination | AKAPDRKAVSEAQEK CCCCCHHHHHHHHHH | 15.80 | 24816145 | |
255 | Ubiquitination | KAVSEAQEKLTESNQ HHHHHHHHHHHHHHH | 58.02 | 24816145 | |
256 | Ubiquitination | AVSEAQEKLTESNQK HHHHHHHHHHHHHHH | 48.94 | 29967540 | |
262 | Ubiquitination | EKLTESNQKLGLLRE HHHHHHHHHHHHHHH | 52.18 | 29967540 | |
263 | Ubiquitination | KLTESNQKLGLLREA HHHHHHHHHHHHHHH | 49.09 | 22817900 | |
263 (in isoform 1) | Ubiquitination | - | 49.09 | 21890473 | |
263 | Ubiquitination | KLTESNQKLGLLREA HHHHHHHHHHHHHHH | 49.09 | 21890473 | |
269 | Ubiquitination | QKLGLLREALERRLG HHHHHHHHHHHHHHC | 58.54 | 21890473 | |
269 (in isoform 2) | Ubiquitination | - | 58.54 | 21890473 | |
275 | Ubiquitination | REALERRLGELPADH HHHHHHHHCCCCCCC | 8.61 | 21890473 | |
301 | Phosphorylation | AASSAAFSTRLAGPF HHHHHHHHHHHCCCC | 14.11 | - | |
311 | Phosphorylation | LAGPFPATHYSTLCK HCCCCCCCCCCCCCC | 22.91 | 20873877 | |
313 | Phosphorylation | GPFPATHYSTLCKPA CCCCCCCCCCCCCCC | 10.05 | 22210691 | |
314 | Phosphorylation | PFPATHYSTLCKPAP CCCCCCCCCCCCCCC | 13.80 | 20873877 | |
315 | Phosphorylation | FPATHYSTLCKPAPL CCCCCCCCCCCCCCC | 29.07 | 20873877 | |
317 (in isoform 2) | Phosphorylation | - | 5.13 | 27251275 | |
323 | Phosphorylation | LCKPAPLTGTLEVRV CCCCCCCCCEEEEEE | 27.36 | 22210691 | |
345 | Phosphorylation | ETIPWNPTPSMGGPG CCCCCCCCCCCCCCC | 25.45 | 26074081 | |
347 | Phosphorylation | IPWNPTPSMGGPGTP CCCCCCCCCCCCCCC | 32.32 | 26074081 | |
353 | Phosphorylation | PSMGGPGTPDSRPPF CCCCCCCCCCCCCCC | 27.36 | 17192257 | |
356 | Phosphorylation | GGPGTPDSRPPFLSR CCCCCCCCCCCCCCC | 48.14 | 26074081 | |
357 | Methylation | GPGTPDSRPPFLSRP CCCCCCCCCCCCCCC | 50.74 | 115386671 | |
359 (in isoform 2) | Phosphorylation | - | 41.52 | 24719451 | |
362 | Phosphorylation | DSRPPFLSRPARGLY CCCCCCCCCCCCCCC | 36.28 | 28122231 | |
366 | Methylation | PFLSRPARGLYSRSG CCCCCCCCCCCCCCC | 38.03 | 54558023 | |
370 | Phosphorylation | RPARGLYSRSGSLSG CCCCCCCCCCCCCCC | 25.64 | 24719451 | |
372 | Phosphorylation | ARGLYSRSGSLSGRS CCCCCCCCCCCCCCH | 27.13 | 28176443 | |
374 | Phosphorylation | GLYSRSGSLSGRSSL CCCCCCCCCCCCHHH | 22.17 | 10467162 | |
376 | Phosphorylation | YSRSGSLSGRSSLKA CCCCCCCCCCHHHHE | 33.58 | 28450419 | |
379 | Phosphorylation | SGSLSGRSSLKAEAE CCCCCCCHHHHEECC | 43.48 | 28450419 | |
380 | Phosphorylation | GSLSGRSSLKAEAEN CCCCCCHHHHEECCC | 32.31 | 10467162 | |
382 | Ubiquitination | LSGRSSLKAEAENTS CCCCHHHHEECCCCC | 46.24 | 32015554 | |
386 (in isoform 2) | Phosphorylation | - | 53.17 | 24719451 | |
388 | Phosphorylation | LKAEAENTSEVSTVL HHEECCCCCCCCEEE | 20.12 | 27251275 | |
388 | Ubiquitination | LKAEAENTSEVSTVL HHEECCCCCCCCEEE | 20.12 | 32015554 | |
389 | Phosphorylation | KAEAENTSEVSTVLK HEECCCCCCCCEEEE | 47.81 | 27251275 | |
392 | Phosphorylation | AENTSEVSTVLKLDN CCCCCCCCEEEEECC | 14.56 | 27251275 | |
393 | Phosphorylation | ENTSEVSTVLKLDNT CCCCCCCEEEEECCE | 34.73 | 27251275 | |
445 | Acetylation | QRGLCALKFLKLEDF CCCCCHHEEECHHHH | 30.08 | 25953088 | |
445 | Ubiquitination | QRGLCALKFLKLEDF CCCCCHHEEECHHHH | 30.08 | - | |
448 | Acetylation | LCALKFLKLEDFLDN CCHHEEECHHHHHCC | 53.62 | 19608861 | |
451 (in isoform 2) | Ubiquitination | - | 60.90 | - | |
454 | Acetylation | LKLEDFLDNERHEVQ ECHHHHHCCCCCEEE | 55.74 | 19608861 | |
495 | Phosphorylation | RRQKKIFSKQQGKAF HHHHHHCHHHHHHHH | 32.78 | 23401153 | |
496 | Ubiquitination | RQKKIFSKQQGKAFQ HHHHHCHHHHHHHHH | 35.57 | - | |
501 | Phosphorylation | FSKQQGKAFQRARQM CHHHHHHHHHHHHHC | 16.78 | 32645325 | |
501 (in isoform 2) | Phosphorylation | - | 16.78 | 24719451 | |
527 | Phosphorylation | RRLIPNATGTGTFSP HHHCCCCCCCCCCCC | 41.75 | 28555341 | |
529 | Phosphorylation | LIPNATGTGTFSPGA HCCCCCCCCCCCCCC | 28.79 | 27134283 | |
531 | Phosphorylation | PNATGTGTFSPGASP CCCCCCCCCCCCCCC | 22.30 | 29255136 | |
533 | Phosphorylation | ATGTGTFSPGASPGS CCCCCCCCCCCCCCC | 23.43 | 29255136 | |
535 (in isoform 2) | Phosphorylation | - | 37.17 | 24719451 | |
537 | Phosphorylation | GTFSPGASPGSEART CCCCCCCCCCCCCCC | 35.39 | 29255136 | |
539 | Phosphorylation | FSPGASPGSEARTTG CCCCCCCCCCCCCCC | 35.31 | 32142685 | |
539 (in isoform 2) | Phosphorylation | - | 35.31 | 24719451 | |
540 | Phosphorylation | SPGASPGSEARTTGD CCCCCCCCCCCCCCC | 31.31 | 29255136 | |
543 | Phosphorylation | ASPGSEARTTGDISV CCCCCCCCCCCCCCE | 28.86 | 32142685 | |
543 (in isoform 2) | Phosphorylation | - | 28.86 | 24719451 | |
544 | Phosphorylation | SPGSEARTTGDISVE CCCCCCCCCCCCCEE | 42.02 | 23312004 | |
545 | Phosphorylation | PGSEARTTGDISVEK CCCCCCCCCCCCEEE | 27.57 | 23312004 | |
549 | Phosphorylation | ARTTGDISVEKLNLG CCCCCCCCEEECCCC | 29.03 | 21815630 | |
557 | Phosphorylation | VEKLNLGTDSDSSPQ EEECCCCCCCCCCCC | 35.18 | 22167270 | |
559 | O-linked_Glycosylation | KLNLGTDSDSSPQKS ECCCCCCCCCCCCCC | 38.95 | 29351928 | |
559 | Phosphorylation | KLNLGTDSDSSPQKS ECCCCCCCCCCCCCC | 38.95 | 22167270 | |
561 | O-linked_Glycosylation | NLGTDSDSSPQKSSR CCCCCCCCCCCCCCC | 48.12 | 29351928 | |
561 | Phosphorylation | NLGTDSDSSPQKSSR CCCCCCCCCCCCCCC | 48.12 | 29255136 | |
562 | Phosphorylation | LGTDSDSSPQKSSRD CCCCCCCCCCCCCCC | 36.02 | 19664994 | |
565 | Ubiquitination | DSDSSPQKSSRDPPS CCCCCCCCCCCCCCC | 54.50 | 24816145 | |
565 (in isoform 2) | Phosphorylation | - | 54.50 | 27251275 | |
566 | Phosphorylation | SDSSPQKSSRDPPSS CCCCCCCCCCCCCCC | 25.92 | 23403867 | |
567 | Phosphorylation | DSSPQKSSRDPPSSP CCCCCCCCCCCCCCC | 47.97 | 19413330 | |
568 (in isoform 2) | Phosphorylation | - | 68.49 | 24719451 | |
571 | Ubiquitination | QKSSRDPPSSPSSLS CCCCCCCCCCCHHCC | 52.29 | 24816145 | |
572 | Phosphorylation | KSSRDPPSSPSSLSS CCCCCCCCCCHHCCC | 61.34 | 23401153 | |
573 | Phosphorylation | SSRDPPSSPSSLSSP CCCCCCCCCHHCCCC | 34.28 | 30278072 | |
575 | Phosphorylation | RDPPSSPSSLSSPIQ CCCCCCCHHCCCCCC | 45.95 | 23401153 | |
576 | Phosphorylation | DPPSSPSSLSSPIQE CCCCCCHHCCCCCCC | 35.34 | 30278072 | |
577 | Ubiquitination | PPSSPSSLSSPIQES CCCCCHHCCCCCCCC | 7.44 | 24816145 | |
578 | Phosphorylation | PSSPSSLSSPIQEST CCCCHHCCCCCCCCC | 35.70 | 23898821 | |
579 | Phosphorylation | SSPSSLSSPIQESTA CCCHHCCCCCCCCCC | 31.17 | 30278072 | |
579 (in isoform 2) | Phosphorylation | - | 31.17 | 27251275 | |
584 | Phosphorylation | LSSPIQESTAPELPS CCCCCCCCCCCCCCC | 17.31 | 30108239 | |
585 | Phosphorylation | SSPIQESTAPELPSE CCCCCCCCCCCCCCC | 45.54 | 30206219 | |
591 | Phosphorylation | STAPELPSETQETPG CCCCCCCCCCCCCCC | 66.94 | 28450419 | |
593 | Phosphorylation | APELPSETQETPGPA CCCCCCCCCCCCCCC | 35.72 | 28464451 | |
596 | Phosphorylation | LPSETQETPGPALCS CCCCCCCCCCCCCCC | 24.59 | 28450419 | |
603 | Phosphorylation | TPGPALCSPLRKSPL CCCCCCCCCCCCCCC | 28.02 | 27050516 | |
607 | Ubiquitination | ALCSPLRKSPLTLED CCCCCCCCCCCCHHH | 65.20 | 29967540 | |
608 | Phosphorylation | LCSPLRKSPLTLEDF CCCCCCCCCCCHHHH | 20.78 | 28348404 | |
611 | Phosphorylation | PLRKSPLTLEDFKFL CCCCCCCCHHHHHHH | 31.33 | 26074081 | |
613 | Ubiquitination | RKSPLTLEDFKFLAV CCCCCCHHHHHHHHE | 57.05 | 29967540 | |
613 (in isoform 2) | Ubiquitination | - | 57.05 | - | |
614 (in isoform 2) | Phosphorylation | - | 55.97 | 27251275 | |
644 | Ubiquitination | SGELFAIKALKKGDI CCCEEEEEEHHHCCE | 44.21 | 29967540 | |
650 | Ubiquitination | IKALKKGDIVARDEV EEEHHHCCEEEHHHH | 40.86 | 29967540 | |
650 (in isoform 2) | Ubiquitination | - | 40.86 | - | |
661 | Sulfoxidation | RDEVESLMCEKRILA HHHHHHHHCHHHHHH | 3.74 | 21406390 | |
664 | Ubiquitination | VESLMCEKRILAAVT HHHHHCHHHHHHHHH | 39.55 | 24816145 | |
670 | Ubiquitination | EKRILAAVTSAGHPF HHHHHHHHHHCCCCC | 3.46 | 24816145 | |
670 (in isoform 2) | Ubiquitination | - | 3.46 | - | |
676 | Ubiquitination | AVTSAGHPFLVNLFG HHHHCCCCCEEHHHC | 24.29 | 24816145 | |
742 | Ubiquitination | KIVYRDLKLDNLLLD CEEECCCCCCCEEEC | 59.07 | 22817900 | |
748 | Ubiquitination | LKLDNLLLDTEGYVK CCCCCEEECCCCCEE | 9.61 | 22817900 | |
754 | Ubiquitination | LLDTEGYVKIADFGL EECCCCCEEHHHCCC | 5.48 | 22817900 | |
763 | Ubiquitination | IADFGLCKEGMGYGD HHHCCCCCCCCCCCC | 63.45 | - | |
768 | Phosphorylation | LCKEGMGYGDRTSTF CCCCCCCCCCCCCCC | 13.63 | 22322096 | |
772 | Phosphorylation | GMGYGDRTSTFCGTP CCCCCCCCCCCCCCC | 36.54 | 23401153 | |
773 | Phosphorylation | MGYGDRTSTFCGTPE CCCCCCCCCCCCCCH | 22.00 | 22322096 | |
774 | Phosphorylation | GYGDRTSTFCGTPEF CCCCCCCCCCCCCHH | 23.49 | 10467162 | |
778 | Phosphorylation | RTSTFCGTPEFLAPE CCCCCCCCCHHHCCH | 22.33 | 21712546 | |
778 (in isoform 2) | Phosphorylation | - | 22.33 | 24719451 | |
779 | Phosphorylation | TSTFCGTPEFLAPEV CCCCCCCCHHHCCHH | 18.67 | 32142685 | |
779 (in isoform 2) | Phosphorylation | - | 18.67 | 27251275 | |
780 | Phosphorylation | STFCGTPEFLAPEVL CCCCCCCHHHCCHHH | 53.80 | 32142685 | |
784 | Phosphorylation | GTPEFLAPEVLTDTS CCCHHHCCHHHCCCC | 34.08 | 32142685 | |
788 | Phosphorylation | FLAPEVLTDTSYTRA HHCCHHHCCCCCHHH | 42.27 | 23403867 | |
790 | Phosphorylation | APEVLTDTSYTRAVD CCHHHCCCCCHHHHH | 20.56 | 23403867 | |
791 | Phosphorylation | PEVLTDTSYTRAVDW CHHHCCCCCHHHHHH | 27.58 | 23403867 | |
792 | Phosphorylation | EVLTDTSYTRAVDWW HHHCCCCCHHHHHHH | 11.44 | 23403867 | |
793 | Phosphorylation | VLTDTSYTRAVDWWG HHCCCCCHHHHHHHH | 16.36 | 23403867 | |
847 | Dimethylation | AEAIGIMRRLLRRNP HHHHHHHHHHHHHCH | 24.95 | - | |
847 | Methylation | AEAIGIMRRLLRRNP HHHHHHHHHHHHHCH | 24.95 | 115372699 | |
869 | Ubiquitination | ERDAEDVKKQPFFRT CCCHHHHHHCHHHHH | 59.00 | 24816145 | |
875 | Ubiquitination | VKKQPFFRTLGWEAL HHHCHHHHHHCHHHH | 29.44 | 24816145 | |
875 (in isoform 2) | Ubiquitination | - | 29.44 | - | |
881 | Ubiquitination | FRTLGWEALLARRLP HHHHCHHHHHHHCCC | 11.02 | 24816145 | |
896 | Phosphorylation | PPFVPTLSGRTDVSN CCCCCCCCCCCCCCC | 28.80 | 26074081 | |
899 | Phosphorylation | VPTLSGRTDVSNFDE CCCCCCCCCCCCCCH | 44.25 | 23403867 | |
902 | Phosphorylation | LSGRTDVSNFDEEFT CCCCCCCCCCCHHHC | 34.29 | 28176443 | |
909 | Phosphorylation | SNFDEEFTGEAPTLS CCCCHHHCCCCCCCC | 37.07 | 28176443 | |
914 | Phosphorylation | EFTGEAPTLSPPRDA HHCCCCCCCCCCCCC | 47.09 | 29255136 | |
916 | Phosphorylation | TGEAPTLSPPRDARP CCCCCCCCCCCCCCC | 35.02 | 19664994 | |
922 | Phosphorylation | LSPPRDARPLTAAEQ CCCCCCCCCCCHHHH | 30.93 | 32142685 | |
922 (in isoform 2) | Phosphorylation | - | 30.93 | 24719451 | |
925 | Phosphorylation | PRDARPLTAAEQAAF CCCCCCCCHHHHHHH | 26.89 | 26074081 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
533 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
537 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
562 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
773 | S | Phosphorylation | Kinase | PDPK1 | O15530 | GPS |
774 | T | Phosphorylation | Kinase | PDK1 | Q15118 | GPS |
774 | T | Phosphorylation | Kinase | PDK1 | O15530 | PSP |
774 | T | Phosphorylation | Kinase | PKN1 | Q16512 | PSP |
916 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PKN1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PKN1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-533; SER-537; SER-559; SER-561; SER-562 ANDSER-916, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-448, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-205; SER-533; SER-537;SER-559; SER-562; THR-914 AND SER-916, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-533; SER-537; SER-559; SER-561; SER-562 ANDSER-916, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-533; SER-537; SER-559;SER-562 AND SER-916, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-205; THR-353; SER-533;SER-537; SER-559 AND SER-916, AND MASS SPECTROMETRY. | |
"Proteomics analysis of protein kinases by target class-selectiveprefractionation and tandem mass spectrometry."; Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,Keri G., Wehland J., Daub H.; Mol. Cell. Proteomics 6:537-547(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-562 AND SER-916, ANDMASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-562, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-376, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-916, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-778, AND MASSSPECTROMETRY. | |
"Phosphorylation of protein kinase N by phosphoinositide-dependentprotein kinase-1 mediates insulin signals to the actin cytoskeleton."; Dong L.Q., Landa L.R., Wick M.J., Zhu L., Mukai H., Ono Y., Liu F.; Proc. Natl. Acad. Sci. U.S.A. 97:5089-5094(2000). Cited for: PHOSPHORYLATION AT THR-774 BY PDPK1, AND INTERACTION WITH PDPK1. |